OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+107.32%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$773M
AUM Growth
+$773M
(+133%)
Cap. Flow
+$85.3M
Cap. Flow
% of AUM
11.04%
Top 10 Holdings %
Top 10 Hldgs %
98.3%
Holding
17
New
2
Increased
7
Reduced
4
Closed
1
Top Buys
| 1 |
AWH
Aspira Women's Health Inc. Common Stock
AWH
|
$39.5M |
| 2 |
Opko Health
OPK
|
$25.8M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$10.3M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$9.53M |
| 5 |
AGEN
Agenus
AGEN
|
$5.35M |
Top Sells
| 1 |
VRML
Vermillion, Inc.
VRML
|
$8.18M |
| 2 |
BIOL
Biolase, Inc.
BIOL
|
$1.97M |
| 3 |
AXDX
Accelerate Diagnostics
AXDX
|
$506K |
| 4 |
Soleno Therapeutics
SLNO
|
$445K |
| 5 |
Biogen
BIIB
|
$316K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
QuidelOrtho
QDEL
$1.95B
| $406M | 51.56% |
1,816,094
+10,111
| +0.6% | +$2.26M |
|
|
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $147M | 18.66% |
2,011,700
+140,957
| +8% | +$10.3M |
|
|
AXDX
3
DELISTED
Accelerate Diagnostics
AXDX
| $61.7M | 7.83% |
4,068,942
-33,345
| -0.8% | -$506K |
|
|
4
Opko Health
OPK
$1.1B
| $41.1M | 5.21% |
12,045,886
+7,572,810
| +169% | +$25.8M |
|
|
AWH
5
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $39.5M | 5.01% |
+10,288,587
| New | +$39.5M |
|
|
AGEN
6
Agenus
AGEN
$133M
| $26.4M | 3.35% |
6,722,460
+1,361,593
| +25% | +$5.35M |
|
|
AMRN
7
Amarin Corp
AMRN
$311M
| $15M | 1.9% |
2,168,142
+332,503
| +18% | +$2.3M |
|
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $9.53M | 1.21% |
+2,000,000
| New | +$9.53M |
|
|
9
Soleno Therapeutics
SLNO
$3.6B
| $8.15M | 1.03% |
3,670,384
-200,243
| -5% | -$445K |
|
|
MOTS
10
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $5.03M | 0.64% |
3,806,666
| – | – |
|
|
ATRS
11
DELISTED
Antares Pharma, Inc.
ATRS
| $4.67M | 0.59% |
1,699,566
+472,452
| +39% | +$1.3M |
|
12
Pacific Biosciences
PACB
$393M
| $4.56M | 0.58% |
1,320,359
+100,000
| +8% | +$345K |
|
13
Y-mAbs Therapeutics
YMAB
$388M
| $1.09M | 0.14% |
25,212
| – | – |
|
|
BIOL
14
DELISTED
Biolase, Inc.
BIOL
| $1M | 0.13% |
1,739,100
-3,434,150
| -66% | -$1.97M |
|
|
15
Biogen
BIIB
$19.4B
| $987K | 0.13% |
3,688
-1,180
| -24% | -$316K |
|
|
CFRX
16
DELISTED
ContraFect Corporation
CFRX
| $823K | 0.1% |
128,845
| – | – |
|
|
VRML
17
DELISTED
Vermillion, Inc.
VRML
| – | – |
-9,825,289
| Closed | -$8.18M |
|